CORONA Remedies Market Cap

CORONA Remedies has a market cap or net worth of 95.86 billion as of March 9, 2026.

Market Cap

95.86B

Enterprise Value

95.95B

Revenue

13.44B

Ranking

n/a

PE Ratio

55.94

Stock Price

1,581.40

Market Cap Chart

Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 95.86B, an increase of 8.97%. That is a compound annual growth rate of 47.26%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	96.72B	14.19%
Dec 31, 2025	84.70B	-3.72%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi India	85.61B
Viyash Scientific	83.27B
Procter & Gamble Health	80.25B
Caplin Point Laboratories	126.80B
Rubicon Research	126.94B
Jubilant Pharmova	130.02B
Granules India	138.64B
FDC Limited	60.58B

Market Cap Rankings